From: Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma
 | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
p value | HR | 95% CI | p value | HR | 95% CI | |
Gender | 0.416 | Â | Â | Â | Â | Â |
Age | 0.116 |  |  | 0.039 | 1.075 | 1.004–1.152 |
Tumor size | 0.458 |  |  | 0.013 | 1.398 | 1.074–1.821 |
Tumor number | 0.717 | Â | Â | Â | Â | Â |
Vascular invasion | 0.375 | Â | Â | Â | Â | Â |
PLT | 0.910 | Â | Â | Â | Â | Â |
ALT | 0.612 | Â | Â | Â | Â | Â |
AFP | 0.004 | 1.000 | 1.000–1.000 |  |  |  |
HbsAg | 0.389 | Â | Â | Â | Â | Â |
HBV-DNA | 0.319 | Â | Â | Â | Â | Â |
Operative time | 0.980 | Â | Â | Â | Â | Â |
Liver cirrhosis | 0.036 | 3.667 | 1.089–12.348 | 0.003 | 18.624 | 2.622–132.303 |
Tumor differentiation | 0.465 | Â | Â | Â | Â | Â |
MVI | 0.456 | Â | Â | Â | Â | Â |
CELSR2 | < 0.01 | 70.672 | 9.450–528.498 | < 0.01 | 1173.999 | 34.682–39,740.677 |